Contract Manufacturing, Finished Drug Product

Catalent Invests Millions to Create European Clinical Manufacturing Center of Excellence

July 21, 2020

Catalent has unveiled investment plans to create a European center of excellence for clinical biologics formulation development and drug product fill/finish services.

Vetter Expands Fill/Finish Capacity with Acquisition of New Site in Austria

July 08, 2020

The acquisition will give the CDMO additional clinical filling options in Europe, which is expected to come online in 2021.

Contractors Balance Increased Demand During COVID-19

July 01, 2020

BioPharm International

The COVID-19 pandemic has created a rise in demand for R&D and a shift in focus for some contract organizations.

Vibalogics Manufactures Clinical Trial Material for Janssen COVID-19 Vaccine Candidate

May 18, 2020

Vibalogics is contracted to manufacture Janssen's COVID-19 candidate vaccine at its GMP-accredited facility in Cuxhaven, Germany.

Fujifilm Diosynth Biotechnologies Reserves Capacity for COVID-19 Therapeutics Accelerator

May 04, 2020

Fujifilm allocates production volumes for COVID-19 treatments in 2021 at its Denmark facility.

More Capacity and Technology Translate to More Options

February 15, 2020

BioPharm International

Technology and capacity investments create opportunities in the cell and gene therapy arena for CDMOs and biopharma alike.

Growth in Biologics Market Inspires Outsourcing

February 01, 2020

BioPharm International

CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.

Catalent Expands Fill-Finish Capacity

January 08, 2020

Catalent completes purchase of biologics fill-finish and oral solid dose facility in Anagni, Italy

Thermo Fisher Scientific Expands Capabilities

November 22, 2019

New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.

Catalent Breaks Ground at $112-Million Drug Product Manufacturing Facility

July 17, 2019

Catalent recently held a groundbreaking ceremony at its Bloomington, Indiana pharmaceutical fill/finish site.